Other content in this Stream
Signant Health Unveils its full Conference Line-up for SCOPE 2020
Subject matter experts, technologists, scientists and executives to advance patient-centric conversations with innovative clinical operations leaders from global pharmaceutical companies.
Signant Health Enhances Audit Trail Reporting Capabilities in TrialMax® to Improve eCOA Data Integrity Monitoring
The new audit features comply with the latest global regulatory guidelines for report design for electronic clinical outcome assessments (eCOA) in clinical trials.
Selecting and Implementing Mobile Sensors to Collect Clinical Trial Endpoint Data
In this webinar learn how to select a device that is acceptable to regulators and patients, implement mobile sensors appropriately within study protocols, and interpret the data they provide.
Building Patient Engagement and Secure Drug Discovery - Data Privacy, Compliance, and Security
Much has been made of the trials and tribulations of complying with data regulations; however, Paul Drake from Signant argues there may be significant opportunities to be gained from data compliance
PharmaVoice - Leveraging Virtual Technology to Improve Processes
In this issue of PharmaVoice, Signant Health's Bill Byrom shares his viewpoint of the potential of virtual health.
Get to Know TrialMax eCOA - Signant Health
When it comes to eCOA – the patient experience matters. Watch this video to learn more about TrialMax.
Signant Health CRO Partner Program
Become a CRO partner today. Sponsors what to know what your competitive edge is, so let's show them. We'll make sure you are distinguished and trusted for delivering across the Signant portfolio.
Electronic Version of the Neurostatus-EDSS Improves MS Trials
University Hospital Basel, Novartis and Signant Health (formerly CRF Health) recently published our experience data on the use of the eEDSS obtained from two phase III Multiple Sclerosis trials.
Neuroscience eClinRO Solution
Get to know our Neuroscience eClinRO solution. An advanced solution that enhances the accuracy and reliability of clinician-rated endpoint data.
Making eCOA Accessible for All Populations
eCOA Design Considerations: Reminders and Alarms
Understanding the Benefits of eCOA in Oncology Clinical Trials
Validating Clinical Trial Data: Paper vs. eCOA
How Does eCOA Help Retain Subjects?
3 Protocol Considerations that Drive eCOA Design
Can Seniors Use Electronic Clinical Outcome Assessments (eCOA)?
eCOA Value: Cost Savings and Beyond
eCOA Data Quality: Site and Patient Perspectives
eCOA Impact on Data Quality